The Results of the Mediterranean Diet for PCOS
PCOS
Prospective Evaluation of the Effects of the Mediterranean Diet on the Reproductive and Metabolic Parameters of Patients Diagnosed With Polycystic Ovary Syndrome (PCOS) and a Body Mass Indexof Over 25 kg/m2
1 other identifier
observational
98
1 country
1
Brief Summary
The aim was to evaluate the effects of the application of a Mediterranean diet on the reproductive and metabolic parameters in the 3rd month in patients with a body mass index of 25 and more who were followed up in our clinic due to a PCOS diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2024
CompletedFirst Posted
Study publicly available on registry
June 4, 2024
CompletedStudy Start
First participant enrolled
September 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 11, 2024
CompletedNovember 19, 2024
November 1, 2024
17 days
May 18, 2024
November 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
the effect of applying a Mediterranean diet on Homa-IR in PCOS
Homeostasis model assessment (HoMA)-IR
3 months
PREDIMED in PCOS
PREDIMED questionnaire
3 months
the effect of applying a Mediterranean diet on glucose in PCOS
Fasting plasma glucose
3 months
the effect of applying a Mediterranean diet on HbA1c in PCOS
HbA1c values
3 months
Study Arms (1)
3. month
Once the baseline values have been determined at the first visit, all tests are repeated after the diet has been followed for 3 months.
Interventions
The aim was to evaluate the effects of the application of a Mediterranean diet on the reproductive and metabolic parameters in the 3rd month of patients with a body mass index of 25 and more who were treated in our clinic due to a diagnosis of PCOS.
Eligibility Criteria
People receiving care at the PCOS Clinic of Etlik Zübeyde Hanım Gynecology Training and Research Hospital who have a body mass index of 25 or more and follow a Mediterranean diet will be included in the study group. 98 subjects who agreed to participate in the study and accepted the informed consent verbally and in writing will be included in the study. The study was designed to be prospective. Data will be collected after 0 and 3 months.
You may qualify if:
- At the age of 18-40 years,
- No underlying metabolic disease (type 2 diabetes, hypertension, diagnosed anemia),
- With a body mass index of 25 and above,
- Female patients attending the PCOS clinic and under the care of our hospital's dietitian will be enrolled in the study.
You may not qualify if:
- Age \< 18 and \> 40 years;
- Menopause, pregnancy or breastfeeding in the last 6 months;
- Hyperandrogenism and/or biochemical hyperandrogenemia due to secondary etiologies, including congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, thyroid dysfunction and adrenal disorders),
- Pre-existing systemic or psychiatric disease
- Use of drugs that affect carbohydrate or lipid metabolism (oral contraceptive pills, metformin, anti-epileptics, antipsychotics, statins and fish oil);
- Certain eating regimens or hypocaloric diet in the last three months; supplementing with antioxidants, vitamins or minerals;
- Non-steroidal anti-inflammatory drugs, diuretics, etc. use of medications that may affect fluid balance
- Female patients with implanted pacemakers or defibrillators due to the theoretical possibility of interference with device activity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Etlik Zübeyde Hanım
Ankara, 06000, Turkey (Türkiye)
Related Publications (2)
Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999 Jan;84(1):165-9. doi: 10.1210/jcem.84.1.5393.
PMID: 9920077RESULTBarrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C, Pugliese G, Colao A, Savastano S. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients. 2019 Sep 23;11(10):2278. doi: 10.3390/nu11102278.
PMID: 31547562RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mujde Can Ibanoglu
Ankara Etlik Zubeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof
Study Record Dates
First Submitted
May 18, 2024
First Posted
June 4, 2024
Study Start
September 20, 2024
Primary Completion
October 7, 2024
Study Completion
November 11, 2024
Last Updated
November 19, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share